FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071566605> ?p ?o ?g. }

• W2071566605 endingPage "1107" @default.
• W2071566605 startingPage "1104" @default.
• W2071566605 abstract "To achieve cost-effective health care in adults, once-daily aminoglycosides administration has been used and judged to be safe and efficacious. A similar strategy in children requires the characterization of pharmacokinetic parameters and the development of a therapeutic monitoring protocol for this antibiotic regimen.A prospective, controlled, randomized (2:1) study was undertaken in 50 pediatric patients between June 1995 and September 1997. Children between 6 months and 18 years who required gentamicin therapy based on independent clinical assessment were eligible if they had normal renal function, no aminoglycoside allergies, were not neutropenic, or did not have cystic fibrosis. Measurements included a peak, 4-hour, 8-hour, and trough gentamicin levels to determine volume of distribution (Vd) and elimination constant (Ke). Ototoxicity and nephrotoxicity were monitored by pre- and postaudiology examinations and serial calculated creatinine clearance determinations, respectively.Thirty-three patients received 7.5 mg/kg every 24 hours, and 17 patients received 2.5 mg/kg every 8 hours. Most frequent indications for treatment were ruptured appendicitis (n = 19) followed by wound infections caused by trauma (n = 4), but the spectrum of treatment was broad including enteric, genitourinary, central nervous system, biliary, ophthalmologic, and orthopedic infections. Pharmacokinetic data indicated that 24-hour dosing resulted in higher peak levels compared with 8-hour dosing (20.4 +/- 45.4 v 7.2 +/- 6.2 mg/L, P < .0001) and lower trough levels (0.29 +/- .02 v 0.69 +/- 0.13, P < .0001), whereas rate of elimination constant and volume of distribution were not significantly different. No nephrotoxicity or ototoxicity has been noted in either group.These data confirm that once-daily dosing of gentamicin is a safe method of treatment that provides equivalent pharmacokinetics compared with traditional dosing and enhances bactericidal effect based on higher peak levels, avoids toxicity, and allows cost savings." @default.
• W2071566605 created "2016-06-24" @default.
• W2071566605 creator A5061519996 @default.
• W2071566605 creator A5066382336 @default.
• W2071566605 creator A5076757103 @default.
• W2071566605 creator A5090286501 @default.
• W2071566605 date "1998-07-01" @default.
• W2071566605 modified "2023-10-16" @default.
• W2071566605 title "Pharmacokinetics of once-daily gentamicin dosing in pediatric patients" @default.
• W2071566605 cites W1987777249 @default.
• W2071566605 cites W2039743226 @default.
• W2071566605 cites W2051710516 @default.
• W2071566605 cites W2076387592 @default.
• W2071566605 cites W2091612898 @default.
• W2071566605 cites W2133831926 @default.
• W2071566605 cites W2143684575 @default.
• W2071566605 cites W2152581854 @default.
• W2071566605 cites W2160535155 @default.
• W2071566605 cites W2164799018 @default.
• W2071566605 cites W2258310355 @default.
• W2071566605 doi "https://doi.org/10.1016/s0022-3468(98)90540-1" @default.
• W2071566605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9694103" @default.
• W2071566605 hasPublicationYear "1998" @default.
• W2071566605 type Work @default.
• W2071566605 sameAs 2071566605 @default.
• W2071566605 citedByCount "38" @default.
• W2071566605 countsByYear W20715666052015 @default.
• W2071566605 countsByYear W20715666052016 @default.
• W2071566605 countsByYear W20715666052017 @default.
• W2071566605 countsByYear W20715666052020 @default.
• W2071566605 countsByYear W20715666052021 @default.
• W2071566605 crossrefType "journal-article" @default.
• W2071566605 hasAuthorship W2071566605A5061519996 @default.
• W2071566605 hasAuthorship W2071566605A5066382336 @default.
• W2071566605 hasAuthorship W2071566605A5076757103 @default.
• W2071566605 hasAuthorship W2071566605A5090286501 @default.
• W2071566605 hasConcept C112705442 @default.
• W2071566605 hasConcept C126189478 @default.
• W2071566605 hasConcept C126322002 @default.
• W2071566605 hasConcept C126894567 @default.
• W2071566605 hasConcept C139254425 @default.
• W2071566605 hasConcept C141071460 @default.
• W2071566605 hasConcept C159641895 @default.
• W2071566605 hasConcept C192670549 @default.
• W2071566605 hasConcept C2775832221 @default.
• W2071566605 hasConcept C2776694085 @default.
• W2071566605 hasConcept C2776938444 @default.
• W2071566605 hasConcept C2777288759 @default.
• W2071566605 hasConcept C2777787772 @default.
• W2071566605 hasConcept C2778239845 @default.
• W2071566605 hasConcept C2778534666 @default.
• W2071566605 hasConcept C2780091579 @default.
• W2071566605 hasConcept C2781413609 @default.
• W2071566605 hasConcept C2909675724 @default.
• W2071566605 hasConcept C2911091166 @default.
• W2071566605 hasConcept C31785415 @default.
• W2071566605 hasConcept C42219234 @default.
• W2071566605 hasConcept C501593827 @default.
• W2071566605 hasConcept C71924100 @default.
• W2071566605 hasConcept C86803240 @default.
• W2071566605 hasConcept C89423630 @default.
• W2071566605 hasConceptScore W2071566605C112705442 @default.
• W2071566605 hasConceptScore W2071566605C126189478 @default.
• W2071566605 hasConceptScore W2071566605C126322002 @default.
• W2071566605 hasConceptScore W2071566605C126894567 @default.
• W2071566605 hasConceptScore W2071566605C139254425 @default.
• W2071566605 hasConceptScore W2071566605C141071460 @default.
• W2071566605 hasConceptScore W2071566605C159641895 @default.
• W2071566605 hasConceptScore W2071566605C192670549 @default.
• W2071566605 hasConceptScore W2071566605C2775832221 @default.
• W2071566605 hasConceptScore W2071566605C2776694085 @default.
• W2071566605 hasConceptScore W2071566605C2776938444 @default.
• W2071566605 hasConceptScore W2071566605C2777288759 @default.
• W2071566605 hasConceptScore W2071566605C2777787772 @default.
• W2071566605 hasConceptScore W2071566605C2778239845 @default.
• W2071566605 hasConceptScore W2071566605C2778534666 @default.
• W2071566605 hasConceptScore W2071566605C2780091579 @default.
• W2071566605 hasConceptScore W2071566605C2781413609 @default.
• W2071566605 hasConceptScore W2071566605C2909675724 @default.
• W2071566605 hasConceptScore W2071566605C2911091166 @default.
• W2071566605 hasConceptScore W2071566605C31785415 @default.
• W2071566605 hasConceptScore W2071566605C42219234 @default.
• W2071566605 hasConceptScore W2071566605C501593827 @default.
• W2071566605 hasConceptScore W2071566605C71924100 @default.
• W2071566605 hasConceptScore W2071566605C86803240 @default.
• W2071566605 hasConceptScore W2071566605C89423630 @default.
• W2071566605 hasIssue "7" @default.
• W2071566605 hasLocation W20715666051 @default.
• W2071566605 hasLocation W20715666052 @default.
• W2071566605 hasOpenAccess W2071566605 @default.
• W2071566605 hasPrimaryLocation W20715666051 @default.
• W2071566605 hasRelatedWork W1996211690 @default.
• W2071566605 hasRelatedWork W2087343213 @default.
• W2071566605 hasRelatedWork W2094502855 @default.
• W2071566605 hasRelatedWork W2139708553 @default.
• W2071566605 hasRelatedWork W2467273834 @default.
• W2071566605 hasRelatedWork W2470204530 @default.
• W2071566605 hasRelatedWork W2555402274 @default.

• next